查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493261

美国细胞培养市场规模、份额、趋势分析报告：按产品、按应用、细分市场预测，2024-2030 年

U.S. Cell Culture Market Size, Share & Trends Analysis Report By Product, By Application (Biopharmaceutical Production, Drug Development, Diagnostics, Tissue Culture & Engineering), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

美国细胞培养市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，到2030年，美国细胞培养市场规模预计将达到109.7亿美元，预计2024年至2030年复合年增长率为10.02%。

市场成长预计将受到多种因素的推动，包括生物相似药和生技药品的成长、干细胞研究的进步以及促进细胞疫苗开发的生物製造技术的出现。

COVID-19 大流行增加了对可靠的细胞疫苗製造技术的需求。此外，它还带来了几项显着的科学突破，特别是在疫苗技术的开发和测试方面。 2021 年 8 月，丹纳赫宣布 Cytiva 和 Pall 扩大生产规模，以支持新冠病毒药物和疫苗的开发，并实现细胞培养和基因治疗等各种模式的生产扩张，以满足大流行期间的需求。

近年来，细胞培养技术取得了长足的进步，其应用范围正在迅速扩大。在生物製药领域，培养哺乳动物细胞的能力使得大量生产复杂的蛋白质为基础的药物成为可能。这提高了生物製药行业的效率、降低了成本并改善了品管。此外，高产细胞株的推出和培养条件的最佳化也有助于提高生产力和可扩展性。例如，2023年6月，Matika Bio在BIO国际大会上宣布了MatiMax细胞株。此细胞株的特征是缩短倍增时间，以减少处理时间，提高转染效率，并以低成本提高滴度。

然而，围绕生命科学产业所使用的动物和动物衍生产品的伦理影响的认识和争论不断增强，在一定程度上阻碍了市场的成长。从动物的饲养条件和手术过程中可能造成的痛苦，到对动物族群的整体影响，人们越来越担心。然而，无血清和无蛋白培养基产品的引入有望克服这些限制。

美国细胞培养市场报告亮点

  • 到 2023 年，消耗品领域将以 58.0% 的最高收益占有率引领市场，预计在预测期内将以最快的复合年增长率成长。同时，生物技术和生物製药公司正在增加研发支出，以开发单株抗体和疫苗等先进生技药品。
  • 从应用来看，生物製药製造领域预计将在 2023 年以 31.9% 的最高收益占有率引领市场，并在预测期内以最快的复合年增长率成长。抗体疗法的技术进步，例如双特异性抗体、抗体片段和抗体衍生物的开发，预计将扩大细胞培养应用的市场模式。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数与趋势

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章 产品经营分析

  • 产品细分仪表板
  • 美国细胞培养市场产品波动分析
  • 2018-2030 年美国细胞培养市场规模与趋势分析（按产品）
  • 消耗品
    • 2018-2030 年消耗品市场估计与预测
    • 血清
    • 试剂
    • 培养基
  • 装置
    • 2018-2030 年设备市场估计与预测
    • 文化体系
    • 培养箱
    • 离心机
    • 冷冻储存装置
    • 生物安全设备
    • 移液

第五章 应用业务分析

  • 使用细分仪表板
  • 美国细胞培养市场应用变化分析
  • 2018-2030 年美国细胞培养市场规模与趋势分析（按应用）
  • 生物製药製造
    • 2018-2030年生物製药生产市场估计与预测
    • 单株抗体
    • 疫苗生产
    • 其他治疗性蛋白质
  • 医药开发
  • 诊断
  • 组织培养与工程
  • 细胞/基因治疗
  • 毒性试验
  • 其他用途

第六章 竞争状况

  • 公司分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • Sartorius AG
    • Danaher
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Corning Inc.
    • Avantor Inc.
    • BD
    • Eppendorf SE
    • Bio-Techne
    • PromoCell GmbH
Product Code: GVR-4-68040-272-0

U.S. Cell Culture Market Growth & Trends:

The U.S. cell culture market size is anticipated to reach USD 10.97 billion by 2030 and is projected to grow at a CAGR of 10.02% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is expected to be driven by various factors, such as the growth of biosimilars and biologics, advancements in stem cell research, and the emergence of bio-manufacturing technologies that facilitate the development of cell-based vaccines.

The COVID-19 pandemic has resulted in an increased demand for reliable cell-based vaccine production technologies. Furthermore, it has led to a few notable scientific breakthroughs, particularly in the development and testing of vaccine technologies. In August 2021, Danaher announced the manufacturing expansion of Cytiva and Pall which assisted in the drug and vaccine development for COVID and enabled expansion in manufacturing of various modalities such as cell culture and gene therapy to meet the demands during the pandemic.

Cell culture technology has witnessed significant advancements over the past few years and the technology is witnessing a rapid expansion in its scope of applications. In the field of biopharmaceuticals, researchers can now produce complex protein-based drugs in large quantities due to the ability to culture mammalian cells. This has led to increased efficiency, reduced costs, and improved quality control in the biopharmaceutical industry. Furthermore, the launch of high-yield cell lines and the optimization of culture conditions have contributed to enhanced productivity and scalability. For instance, in June 2023, Matica Bio launched its MatiMax cell lines at the BIO International Convention. The cell line features faster doubling times to reduce processing timelines, has enhanced transfection efficiencies, and enables increased titer production at a lower cost.

However, the growing awareness and debate surrounding the ethical implications of animals and animal-based products used in the life sciences industry is impeding market growth to a certain extent. Concerns ranging from conditions in which animals are housed and potential pain caused during procedures to the overall impact on the animal population are growing. However, the introduction of serum-free, protein-free media products is expected to overcome these limitations.

U.S. Cell Culture Market Report Highlights:

  • The consumables segment led the market with the largest revenue share of 58.0% in 2023 and are expected to grow at the fastest CAGR during the forecast period. This is attributed to the increased R&D expenditure by biotechnology & biopharmaceutical businesses to develop sophisticated biologics, such as monoclonal antibodies & vaccines
  • Based on application, the biopharmaceutical production segment led the market with the largest revenue share of 31.9% in 2023 and is expected to grow at the fastest CAGR during the forecast period. The technological advancements in antibody therapeutics, such as the development of bispecific antibodies, antibody fragments, and antibody derivatives, are anticipated to expand the market prospects for applications of cell culture

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product Segment
    • 1.1.2. Application Segment
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Primary Research
  • 1.5. Information or Data Analysis:
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objective

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables &Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expansion in the scope of applications for cell culture technology
      • 3.2.1.2. Rising demand for biopharmaceuticals, artificial organs, & vaccine production
      • 3.2.1.3. Growth in demand for serum-free, specialty, and customized media
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent process control in cell culture techniques
      • 3.2.2.2. Scalability issues with culturing methods
      • 3.2.2.3. Ethical concerns regarding the use of animals
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. U.S. Cell Culture Market Product Movement Analysis
  • 4.3. U.S. Cell Culture Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Sera
      • 4.4.2.1. Sera market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Fetal Bovine Serum
      • 4.4.2.2.1. Fetal bovine serum market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. Other
      • 4.4.2.3.1. Other market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Reagents
      • 4.4.3.1. Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.2. Albumin
      • 4.4.3.2.1. Albumin market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.3. Other
      • 4.4.3.3.1. Other market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Media
      • 4.4.4.1. Media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2. Serum-free Media
      • 4.4.4.2.1. Serum-free media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2.2. CHO Media
      • 4.4.4.2.2.1. CHO media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2.3. HEK 293 Media
      • 4.4.4.2.3.1. HEK 293 media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2.4. BHK Medium
      • 4.4.4.2.4.1. BHK medium market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2.5. Vero Medium
      • 4.4.4.2.5.1. Vero medium market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2.6. Other Serum-free Media
      • 4.4.4.2.6.1. Other serum-free media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.3. Classical Media
      • 4.4.4.3.1. Classical media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.4. Stem Cell Culture Media
      • 4.4.4.4.1. Stem cell culture media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.5. Chemically Defined Media
      • 4.4.4.5.1. Chemically defined media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.6. Specialty Media
      • 4.4.4.6.1. Specialty media market estimates and forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.7. Other Cell Culture Media
      • 4.4.4.7.1. Other cell culture media market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Culture Systems
      • 4.5.2.1. Culture systems market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Incubators
      • 4.5.3.1. Incubators market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Centrifuges
      • 4.5.4.1. Centrifuges market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Cryostorage Equipment
      • 4.5.5.1. Cryostorage equipment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Biosafety Equipment
      • 4.5.6.1. Biosafety equipment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.7. Pipetting
      • 4.5.7.1. Pipetting market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. Cell Culture Market Application Movement Analysis
  • 5.3. U.S. Cell Culture Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Biopharmaceutical Production
    • 5.4.1. Biopharmaceutical production market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Monoclonal Antibodies
      • 5.4.2.1. Monoclonal antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Vaccine Production
      • 5.4.3.1. Vaccine production market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Other Therapeutic Proteins
      • 5.4.4.1. Other therapeutic proteins market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Drug Development
    • 5.5.1. Drug development market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Diagnostics
    • 5.6.1. Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Tissue Culture and Engineering
    • 5.7.1. Tissue culture and engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8. Cell & Gene Therapy
    • 5.8.1. Cell & gene therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.9. Toxicity Testing
    • 5.9.1. Toxicity testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.10. Other Application
    • 5.10.1. Other applications market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Position Analysis, 2023
  • 6.4. Company Profiles/Listing
    • 6.4.1. Sartorius AG
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. Danaher
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Merck KGaA
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Thermo Fisher Scientific, Inc.
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Corning Inc.
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Avantor Inc.
      • 6.4.6.1. Overview Avantor Inc.
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. BD
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Eppendorf SE
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. Bio-Techne
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. PromoCell GmbH
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary sources
  • Table 3 U.S. cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 5 Key companies undergoing expansions
  • Table 6 Key companies undergoing acquisitions
  • Table 7 Key companies undergoing collaborations
  • Table 8 Key companies launching new products
  • Table 9 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. cell culture market: market outlook
  • Fig. 7 U.S. cell culture competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 U.S. cell culture market driver impact
  • Fig. 10 U.S. cell culture market restraint impact
  • Fig. 11 U.S. cell culture market: Product movement analysis
  • Fig. 12 U.S. cell culture market: Product outlook and key takeaways
  • Fig. 13 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Sera market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Fetal bovine serum market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Albumin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Serum-free media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 CHO media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 HEK 293 media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 BHK medium market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Vero medium market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Other serum-free media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Classical media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Stem cell culture media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Chemically defined media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Specialty media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Other cell culture media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Culture systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Incubators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Centrifuges market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Cryostorage equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Biosafety equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Pipetting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 U.S cell culture market: Application movement analysis
  • Fig. 40 U.S cell culture market: Application outlook and key takeaways
  • Fig. 41 Biopharmaceutical production market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Vaccines production market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Other therapeutic proteins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Drug development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Tissue culture & engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Cell & gene therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Toxicity testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Market positioning of key market players - U.S cell culture market